Artwork

Innhold levert av Perplexity. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Perplexity eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

AI-Developed Drugs Coming Soon, Finland Signs Artemis Accords, and JFK, MLK Files Declassified

7:03
 
Del
 

Manage episode 463522122 series 3554250
Innhold levert av Perplexity. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Perplexity eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

We're experimenting and would love to hear from you!

In this episode of 'Discover Daily', we delve into the groundbreaking advancements in AI-driven drug discovery, highlighting DeepMind's AlphaFold 3 and significant partnerships between Isomorphic Labs and pharmaceutical giants Eli Lilly and Novartis. The episode explores how these collaborations, backed by substantial investments reaching into billions, are revolutionizing the development of small molecule therapeutics and accelerating the traditionally lengthy drug development process.
We then shift to Finland's historic entry into the Artemis Accords as the 53rd nation and first signatory of 2025, marking a significant milestone in international space cooperation. This strategic move not only demonstrates Finland's commitment to peaceful space exploration but also positions the country to benefit from potential investment returns and enhanced polar region monitoring capabilities in response to increasing climate change impacts.
The episode concludes with a detailed examination of a new executive order mandating the declassification of remaining files related to the assassinations of JFK, RFK, and MLK Jr. This unprecedented move towards transparency sets specific timelines for intelligence agencies to develop comprehensive release plans, potentially unveiling new insights into these pivotal moments in American history while addressing decades of public interest in these historical events.
From Perplexity's Discover Feed:
https://www.perplexity.ai/page/ai-developed-drugs-coming-soon-KafDx1.USaWRvWfDBgYk.g

https://www.perplexity.ai/page/finland-signs-artemis-accords-SJdroKJERvqYlwwVm9z_pQ

https://www.perplexity.ai/page/trump-signs-executive-order-to-rUYlBy8tR1yBhoZc8YhyCg

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.
Take the world's knowledge with you anywhere. Available on iOS and Android
Join our growing Discord community for the latest updates and exclusive content.
Follow us on:

  continue reading

265 episoder

Artwork
iconDel
 
Manage episode 463522122 series 3554250
Innhold levert av Perplexity. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Perplexity eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

We're experimenting and would love to hear from you!

In this episode of 'Discover Daily', we delve into the groundbreaking advancements in AI-driven drug discovery, highlighting DeepMind's AlphaFold 3 and significant partnerships between Isomorphic Labs and pharmaceutical giants Eli Lilly and Novartis. The episode explores how these collaborations, backed by substantial investments reaching into billions, are revolutionizing the development of small molecule therapeutics and accelerating the traditionally lengthy drug development process.
We then shift to Finland's historic entry into the Artemis Accords as the 53rd nation and first signatory of 2025, marking a significant milestone in international space cooperation. This strategic move not only demonstrates Finland's commitment to peaceful space exploration but also positions the country to benefit from potential investment returns and enhanced polar region monitoring capabilities in response to increasing climate change impacts.
The episode concludes with a detailed examination of a new executive order mandating the declassification of remaining files related to the assassinations of JFK, RFK, and MLK Jr. This unprecedented move towards transparency sets specific timelines for intelligence agencies to develop comprehensive release plans, potentially unveiling new insights into these pivotal moments in American history while addressing decades of public interest in these historical events.
From Perplexity's Discover Feed:
https://www.perplexity.ai/page/ai-developed-drugs-coming-soon-KafDx1.USaWRvWfDBgYk.g

https://www.perplexity.ai/page/finland-signs-artemis-accords-SJdroKJERvqYlwwVm9z_pQ

https://www.perplexity.ai/page/trump-signs-executive-order-to-rUYlBy8tR1yBhoZc8YhyCg

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.
Take the world's knowledge with you anywhere. Available on iOS and Android
Join our growing Discord community for the latest updates and exclusive content.
Follow us on:

  continue reading

265 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2025 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett
Lytt til dette showet mens du utforsker
Spill